StockData
CV Sciences, Inc. logo

CV Sciences, Inc. (CVSI) stock

CVSIOTCPharmaceutical PreparationsFiscal year ends December 31
Financials through Q3 FY2026, quarter ended Sep 30, 2026Last filing: 10-Q on Nov 13, 2026Score 7/30
$0.01−0.00 (-21.13%)

Close on Oct 19, 2026Market cap $2.53MP/E –Yield –

CV Sciences revenue

Revenue is the money a company takes in from selling its products and services, before any costs are deducted.

CV Sciences's revenue for the twelve months ending Sep 30, 2026 was $12.52M, down 12.9% year over year. For fiscal 2025 it was $13.79M, down 12.2% from the year before. Over ten years it grew 1.8% a year on average. The highest annual figure on record is $53.70M in fiscal 2019.

Annual revenue

PeriodPeriod endValueChange
FY2025Dec 31, 2025$13.79M-12.2%
FY2024Dec 31, 2024$15.71M-1.9%
FY2023Dec 31, 2023$16.00M-1.2%
FY2022Dec 31, 2022$16.21M-19.2%
FY2021Dec 31, 2021$20.05M-17.9%
FY2020Dec 31, 2020$24.43M-54.5%
FY2019Dec 31, 2019$53.70M+11.3%
FY2018Dec 31, 2018$48.24M+133.3%
FY2017Dec 31, 2017$20.68M+87.0%
FY2016Dec 31, 2016$11.06M-4.1%
FY2015Dec 31, 2015$11.53M+13.1%
FY2014Dec 31, 2014$10.19M+373.1%
FY2013Dec 31, 2013$2.15M–
FY2012Dec 31, 2012$0–

Quarterly revenue

Change is against the same quarter a year earlier.

PeriodPeriod endValueChange
Q3 FY2026Sep 30, 2026$3.03M-7.0%
Q2 FY2026Jun 30, 2026$2.99M-17.5%
Q1 FY2026Mar 31, 2026$3.20M-11.4%
Q4 FY2025Dec 31, 2025$3.31M-14.9%
Q3 FY2025Sep 30, 2025$3.26M-15.8%
Q2 FY2025Jun 30, 2025$3.62M-8.4%
Q1 FY2025Mar 31, 2025$3.61M-9.9%
Q4 FY2024Dec 31, 2024$3.88M+2.2%
Q3 FY2024Sep 30, 2024$3.87M-5.5%
Q2 FY2024Jun 30, 2024$3.95M-0.3%
Q1 FY2024Mar 31, 2024$4.00M-3.5%
Q4 FY2023Dec 31, 2023$3.80M-1.8%
Q3 FY2023Sep 30, 2023$4.09M+9.0%
Q2 FY2023Jun 30, 2023$3.97M-4.2%
Q1 FY2023Mar 31, 2023$4.15M-6.7%
Q4 FY2022Dec 31, 2022$3.87M-22.1%
Q3 FY2022Sep 30, 2022$3.75M-26.6%
Q2 FY2022Jun 30, 2022$4.14M-19.3%
Q1 FY2022Mar 31, 2022$4.45M-8.2%
Q4 FY2021Dec 31, 2021$4.97M-4.4%
Q3 FY2021Sep 30, 2021$5.11M-8.2%
Q2 FY2021Jun 30, 2021$5.13M-5.0%
Q1 FY2021Mar 31, 2021$4.84M-41.4%
Q4 FY2020Dec 31, 2020$5.20M-44.3%
Q3 FY2020Sep 30, 2020$5.56M-55.9%
Q2 FY2020Jun 30, 2020$5.40M-68.0%
Q1 FY2020Mar 31, 2020$8.27M-44.5%
Q4 FY2019Dec 31, 2019$9.33M-34.4%
Q3 FY2019Sep 30, 2019$12.60M-7.3%
Q2 FY2019Jun 30, 2019$16.85M+36.5%
Q1 FY2019Mar 31, 2019$14.91M+84.7%
Q4 FY2018Dec 31, 2018$14.22M+96.4%
Q3 FY2018Sep 30, 2018$13.60M+143.3%
Q2 FY2018Jun 30, 2018$12.35M+202.5%
Q1 FY2018Mar 31, 2018$8.07M+114.4%
Q4 FY2017Dec 31, 2017$7.24M+125.6%
Q3 FY2017Sep 30, 2017$5.59M–
Q2 FY2017Jun 30, 2017$4.08M–
Q1 FY2017Mar 31, 2017$3.76M–
Q4 FY2016Dec 31, 2016$3.21M–

More CV Sciences figures

See a number that looks wrong?